
Clene Inc.
CLNNNASDAQHealthcare● Active
$5.60
+$0.27(+5.09%)
Market Cap$57735444
P/E Ratio—
52W High$13.5
52W Low$3.25
Clene Inc.(CLNN)· 损益表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q(经 FMP 聚合)· 可在下方切换周期与 M/B/T 单位。
FMP · CLNN · 截至 2026-06-09
财务报表
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $0.20M | $0.34M | $0.65M | $0.47M | $0.72M |
| Cost of Revenue | $0.04M | $0.07M | $0.12M | $0.03M | $0.29M |
| Gross Profit | $0.16M | $0.27M | $0.53M | $0.45M | $0.43M |
| Gross Margin %(computed) | 78.50% | 79.53% | 81.50% | 94.50% | 60.03% |
| Operating Expenses | |||||
| R&D Expenses | $14.01M | $20.06M | $26.66M | $31.92M | $28.42M |
| G&A Expenses | $9.23M | $13.31M | $14.42M | $16.16M | $18.81M |
| Total Operating Expenses | $23.24M | $33.37M | $41.07M | $48.86M | $50.41M |
| Operating Income | ($23.08M) | ($33.09M) | ($40.54M) | ($48.41M) | ($49.98M) |
| Operating Margin %(computed) | — | — | — | — | — |
| Interest Income | $0.22M | $0.86M | $1.39M | $0.00M | $0.00M |
| Interest Expense | $2.68M | $4.06M | $4.56M | $3.30M | $0.87M |
| Income Before Tax | ($26.17M) | ($39.40M) | ($49.50M) | ($29.92M) | ($10.17M) |
| Income Tax Expense | $0.00M | $0.00M | $0.00M | $0.00M | ($0.43M) |
| Net Income | ($26.17M) | ($39.40M) | ($49.50M) | ($29.92M) | ($9.74M) |
| Net Margin %(computed) | — | — | — | — | — |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-2.65 | $-5.67 | $-9.43 | $-4.69 | $-3.16 |
| Wtd Avg Shares | 9.86M | 6.95M | 5.25M | 3.26M | 3.08M |
| EBITDA | ($21.59M) | ($33.69M) | ($43.24M) | ($25.60M) | ($8.34M) |
| EBITDA Margin %(computed) | — | — | — | — | — |
数据来源:Financial Modeling Prep · 最后更新:2026-06-09 · USD · M
深入了解Clene Inc.
关于Clene Inc.(CLNN)损益表
Clene Inc.(CLNN)损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年,CLNN实现营收$0.00B,毛利润$0.00B(毛利率78.50%),净利润($0.03B)(净利率-13086.50%)。
常见问题
CLNN · 4 问Clene Inc.(CLNN)2025财年营收为$0.00B,同比down41.5%。
CLNN revenueCLNN salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09